Table 3. Type and Intensity of Statin Therapy.

Daily statin	All patients (n = 213)	(A) Patients on MIST with normal cognitive function (n = 133)	(B) Patients on MIST with cognitive impairment (n = 8)	P (A vs. B)	(C) Patients on HIST with normal cognitive function (n = 42)	(D) Patients on HIST with cognitive impairment (n = 30)	P (C vs. D)
Atorvastatin 40 - 80 mg, n (%)	50 (23.5%)				30 (71.3%)	20 (66.7%)	0.796
Rosuvastatin 20 - 40 mg, n (%)	22 (10.3%)				12 (28.7%)	10 (33.3%)	0.665
Atorvastatin 10 - 20 mg, n (%)	40 (18.8%)	36 (27.1%)	4 (50%)	0.217
Rosuvastatin 10 mg, n (%)	23 (10.8%)	21 (15.8%)	2 (25%)	0.617
Simvastatin 20 - 40 mg, n (%)	40 (18.8%)	39 (29.3%)	1 (12.5%)	0.440
Pravastatin 40 - 80 mg, n (%)	13 (6.1%)	12 (9%)	1 (12.5%)	0.548
Lovastatin 40 mg, n (%)	8 (3.8%)	8 (6%)	0 (0%)	1.000
Fluvastatin XL 80 mg, n (%)	6 (2.8%)	6 (4.5%)	0 (0%)	1.000
Fluvastatin 40 mg BID, n (%)	4 (1.9%)	4 (3%)	0 (0%)	1.000
Pitavastatin 2 - 4 mg, n (%)	7 (3.3%)	7 (5.3%)	0 (0%)	1.000

MIST: moderate-intensity statin therapy; HIST: high-intensity statin therapy; BID: twice a day.